Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Open Forum Infectious Diseases|June 29, 2023
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test CaseAna M Ortega-Villa, Noreen A Hynes, Corri B Levine, et al.
Research Square|March 10, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
Trials|March 21, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
JAMA Network Open|September 25, 2025
Olfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult CohortLeora I Horwitz, Jacqueline H Becker, Weixing Huang, et al.
The Lancet. Respiratory Medicine|October 21, 2021
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trialAndre C Kalil, Aneesh K Mehta, Thomas F Patterson, et al.
Critical Care Medicine|October 27, 2022
Wellness and Coping of Physicians Who Worked in ICUs During the Pandemic: A Multicenter Cross-Sectional North American SurveyKaren E A Burns, Marc Moss, Edmund Lorens, et al.
The Lancet. Respiratory Medicine|May 26, 2022
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trialCameron R Wolfe, Kay M Tomashek, Thomas F Patterson, et al.
Plos One|June 23, 2023
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and designLeora I Horwitz, Tanayott Thaweethai, Shari B Brosnahan, et al.
Pageof 6